Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 26, Number 3—March 2020
Research

Acquisition of Plasmid with Carbapenem-Resistance Gene blaKPC2 in Hypervirulent Klebsiella pneumoniae, Singapore

Yahua Chen, Kalisvar Marimuthu, Jeanette Teo, Indumathi Venkatachalam, Benjamin Pei Zhi Cherng, Liang De Wang, Sai Rama Sridatta Prakki, Weizhen Xu, Yi Han Tan, Lan Chi Nguyen, Tse Hsien Koh, Oon Tek Ng, and Yunn-Hwen GanComments to Author 
Author affiliations: National University of Singapore, Singapore (Y. Chen, Y.H. Tan, L.C. Nguyen, Y.-H. Gan); National Centre for Infectious Diseases, Singapore (K. Marimuthu, L.D. Wang, S.R.S. Prakki, W. Xu, O.T. Ng); Tan Tock Seng Hospital, Singapore (K. Marimuthu, O.T. Ng); National University Hospital, Singapore (J. Teo); Singapore General Hospital, Singapore (I. Venkatachalam, B.P.Z. Cherng, T.H. Koh); Nanyang Technological University, Singapore (O.T. Ng)

Cite This Article

Abstract

The convergence of carbapenem-resistance and hypervirulence genes in Klebsiella pneumoniae has led to the emergence of highly drug-resistant superbugs capable of causing invasive disease. We analyzed 556 carbapenem-resistant K. pneumoniae isolates from patients in Singapore hospitals during 2010–2015 and discovered 18 isolates from 7 patients also harbored hypervirulence features. All isolates contained a closely related plasmid (pKPC2) harboring blaKPC-2, a K. pneumoniae carbapenemase gene, and had a hypervirulent background of capsular serotypes K1, K2, and K20. In total, 5 of 7 first patient isolates were hypermucoviscous, and 6 were virulent in mice. The pKPC2 was highly transmissible and remarkably stable, maintained in bacteria within a patient with few changes for months in the absence of antimicrobial drug selection pressure. Intrapatient isolates were also able to acquire additional antimicrobial drug resistance genes when inside human bodies. Our results highlight the potential spread of carbapenem-resistant hypervirulent K. pneumoniae in Singapore.

The rise of multidrug-resistant (MDR) Enterobacteriaceae prompted the World Health Organization to classify carbapenem-resistant Enterobacteriaceae, of which Klebsiella is the most common genus, on the global priority list of antibiotic-resistant bacteria in 2017 (1). Carbapenem-resistant K. pneumoniae (CRKP, also including K. quasipneumoniae) infections are generally hospital acquired, particularly among elderly and immunocompromised patients (2,3). The major carbapenemases include K. pneumoniae carbapenemase (KPC), New Delhi metallo-β-lactamase, and carbapenem-hydrolyzing class D β-lactamase (OXA), all of which have spread globally (47).

The Carbapenemase-Producing Enterobacteriaceae in Singapore (CaPES) study initiated in 2013 revealed that the rate of incident carbapenem-resistant Enterobacteriaceae clinical cultures in government hospitals in Singapore increased during 2011–2013 and plateaued thereafter (8). The number of cases of hypervirulent K. pneumoniae has increased in the past 3 decades in parts of Asia, and likewise, the number of cases of monomicrobial Klebsiella-induced liver abscesses has also increased (9,10).

The prevalence of antimicrobial resistance among hypervirulent K. pneumoniae isolates is rare compared with that of standard isolates (11,12); hypervirulent K. pneumoniae and CRKP seem to have their own particular reservoirs and remain mostly segregated from each other. However, hypervirulent K. pneumoniae and CRKP isolates can converge in the same organism, leading to the emergence of superbugs resistant to antimicrobial drugs of even the last line of treatment that are capable of infecting healthy persons. This emergence has already been reported in China, Brazil, and the United Kingdom (1315). The fatal outbreak that occurred in a hospital in China in 2016 was caused by a carbapenem-resistant hypervirulent K. pneumoniae strain that had acquired a virulence plasmid by a classic sequence type (ST) 11 strain (16). In a study of a collection of >2,200 K. pneumoniae genomes, distinct evolutionary patterns of horizontal gene transfer were observed in MDR isolates versus hypervirulent isolates (17). The authors of that study postulated that hypervirulent clones might be subject to some sort of constraint against horizontal gene transfer and show more conserved pangenomic diversity than MDR clones. If that hypothesis is correct, MDR clones acquiring virulence genes or K. pneumoniae virulence plasmids would be more likely than hypervirulent clones acquiring MDR genes. To investigate this hypothesis, we searched for hypervirulent isolates among 556 CRKP isolates collected at public hospitals of Singapore.

Materials and Methods

Bacterial Isolates and Microbiologic Methods

During 2010–2015, all microbiology laboratories in Singapore had been mandated to submit their carbapenem-resistant Enterobacteriaceae isolates to the National Public Health Laboratory of Singapore. Using this library, we collected isolates from the CaPES study. We performed species identification, assessed carbapenem resistance, and determined carbapenemase genes as previously described (8).

Whole-Genome Sequencing and Data Analysis

We performed whole-genome sequencing using the MiSeq platform (Illumina, https://www.illumina.com) as previously described (18). In addition, we sequenced the complete genomes of 5 isolates from 3 patients, obtaining long reads using the GridION X5 system (Oxford Nanopore Technologies, https://nanoporetech.com) to close the gaps. We de novo assembled the Illumina sequence reads using SPAdes 3.11.1 (19) and completed genome assembly using a combination of Illumina and Oxford Nanopore Technologies data with the hybrid assembler Unicycler version 0.4.7 (Appendix Table) (20). We deposited whole-genome sequencing data in GenBank (BioProject numbers PRJNA342893, PRJNA557813, and PRJNA591409). We screened genome assemblies for virulence loci and K. pneumoniae virulence plasmid–associated loci using kleborate (2123). We resolved missing loci and ambiguous alleles by mapping short reads to reference sequences using breseq (24) and screened assemblies for antimicrobial resistance genes using ResFinder 3.1 (25) and CARD (26). We resolved any discrepancies between these 2 gene identifiers by searching blastp (https://blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE=Proteins) using translated gene sequences. We identified plasmid replicons in all completely sequenced genomes using PlasmidFinder with default settings (27). For all isolates, we performed core-genome single-nucleotide polymorphism (SNP) analysis against reference genome SGH10 chromosome (GenBank accession no. CP025080) using Parsnp 1.2 (28). In plasmid analyses, we generated alignments by mapping assemblies to reference plasmids using bowtie2 (29) on the REALPHY server (30). We inferred approximate maximum-likelihood phylogenetic trees using FastTree 2 (31) and screened completed assemblies for origin of transfer (oriT) sites and other transfer-related modules using oriTfinder (32).

Determining Hypermucoviscosity

We assessed hypermucoviscosity of all isolates using the string test (33) and a quantitative centrifugation assay (34). We used SGH10 as the positive control and SGH10 with rmpA deleted as the negative control.

Mouse Infection

We infected female 7–8-week-old C57BL/6J mice (InVivos, http://www.invivos.com.sg) with 1 × 105 CFU of bacteria diluted in 100 μL phosphate-buffered saline through the intraperitoneal route and assessed for death every 8–16 h. Animal experiments were approved under protocol R18–0252 by the National University of Singapore Institutional Animal Care and Use Committee in accordance with the National Advisory Committee for Laboratory Animal Research guidelines.

Conjugation Experiments

We measured the transmissibility of the blaKPC-2–carrying plasmid using a previously described method (35). In this experiment, carbapenem-resistant hypervirulent K. pneumoniae isolates were the donors and a kanamycin-resistant Escherichia coli MG1655 mutant SLC568 strain (36) was the recipient. We carried out conjugation on 0.22-µm nitrocellulose filters with donors and recipients incubated at a 1:1 ratio on lysogeny broth (LB) agar plates for 4 h at 37°C. We enumerated transconjugants on LB agar plates containing carbenicillin (100 µg/mL) and kanamycin (50 µg/mL) and recipients on LB agar plates containing kanamycin only. We confirmed transfer of the blaKPC-2 gene by PCR.

Antimicrobial Susceptibility Testing

We performed antimicrobial susceptibility testing following the Clinical and Laboratory Standards Institute guidelines. We determined MICs (37) and interpreted breakpoints (38) of antimicrobial drugs as described.

Statistical Methods

We performed statistical analyses using GraphPad Prism version 8 (https://www.graphpad.com). We compared samples using the unpaired t-test with Welch correction.

Results

Discovery of Hypervirulent Features of CRKP

We retrieved 1,312 carbapenem-resistant Enterobacteriaceae collected from 6 public hospitals in Singapore during 2010–2015 through the CaPES program and National Public Health Laboratory of Singapore; 1,251 isolates were whole-genome sequenced with Illumina technology, and 556 isolates were K. pneumoniae. We searched K. pneumoniae isolate genomes for the presence of K. pneumoniae virulence plasmid–associated virulence determinants, rmpA, rmpA2, iro (the salmochelin locus), and iuc (the aerobactin locus) by using kleborate. We identified 18 isolates (originating from just 7 patients) harboring all of these loci, and 14 of these isolates came from the same 3 patients. We screened the genome assemblies of these 18 isolates for virulence features and compared the characteristics of these isolates with those of 2 known hypervirulent strains, SGH10 (serotype K1 liver abscess–associated isolate from Singapore) (6,39) and CG43 (serotype K2 clinical isolate from Taiwan) (40). We then performed a phylogenetic analysis of the core genomes of all these isolates.

Figure 1

Thumbnail of Maximum-likelihood trees of genes from carbapenem-resistant Klebsiella pneumoniae isolates, Singapore, 2013–2015. A) Analysis generated using 63,297 single-nucleotide polymorphism sites in the core genome. The chromosomal sequence of SGH10 (GenBank accession no. CP025080) was used as reference. Isolates are closely related to hypervirulent strains SGH10 and CG43. Scale bar indicates number of single-nucleotide polymorphisms. B) Analysis generated from the alignment of K. pneumoniae

Figure 1. Maximum-likelihood trees of genes from carbapenem-resistant Klebsiella pneumoniae isolates, Singapore, 2013–2015. A) Analysis generated using 63,297 single-nucleotide polymorphism sites in the core genome. The chromosomal sequence of SGH10 (GenBank accession no....

The differences found among isolates from the same patient were small (0–15 SNPs) (Figure 1, panel A), suggesting that patients with multiple isolates were infected with a single strain. All isolates from patients A2, A4, and A6 were ST23 and serotype K1 (same as SGH10) and, except for ENT1256, carried the same virulence loci as SGH10 (Table 1); ENT1256 had a different allele for rmpA2. The core genomes of these isolates were also similar to SGH10, as shown by the phylogenetic analysis (Figure 1, panel A). However, the differences between isolates from patients A2, A4, and A6 were much greater (200–300 SNPs) than the differences between isolates from patient A2 (15 SNPs), indicating that the bacteria from these patients were unlikely to have originated from the same strain. The isolates from patients A14 and A15 were the same serotype (K2) but different sequence types (Table 1), and their core genomes contained many differences (>20,000 SNPs). The isolates from patient A14 were phylogenetically close to the other hypervirulent strain, CG43 (Figure 1, panel A); however, unlike CG43, which carried no yersiniabactin (ybt) and colibactin (clb) loci, 2 A14 isolates (ENT1192 and ENT1988) had a ybt 9 locus on integrative conjugative element K. pneumoniae 3 (Table 1). The isolates from the remaining 2 patients (A8 and A12) were the same serotype (K20) but had different sequence types and many core genome differences (>20,000 SNPs). ENT1332 had an unknown ybt locus, and ENT1381 had a ybt 9 locus on integrative conjugative element K. pneumoniae 3. Both of these isolates did not have the clb locus. All isolates had hypervirulence backgrounds.

We also performed a whole-genome phylogenetic analysis on the K. pneumoniae virulence plasmid carried in the first isolates obtained from all patients, using the K. pneumoniae virulence plasmid sequence from SGH10 (pSGH10) as reference. The K. pneumoniae virulence plasmids appeared to form 2 separate clades, 1 for all K1 isolates and the other for K2 and K20 isolates (Figure 1, panel B).

Figure 2

Thumbnail of Hypervirulence assessment of first isolates from 7 patients with CRKP infections, Singapore, 2013–2015. A) Hypermucoviscosity of isolates as indicated by a low-speed centrifugation assay and the string test. For the centrifugation assay, Klebsiella pneumoniae isolates were grown in Luria broth overnight at 37°C and centrifuged (10 minutes at 2,000 × g), and OD600s of supernatants were measured. Each symbol represents the value for an individual clone (n = 10) from 3 independent expe

Figure 2. Hypervirulence assessment of first isolates from 7 patients with CRKP infections, Singapore, 2013–2015. A) Hypermucoviscosity of isolates as indicated by a low-speed centrifugation assay and the string test. For the centrifugation...

The virulence potentials of all isolates were high (Table 1); the virulence scores predicted by kleborate for all isolates (>4) were higher than the score (3) predicted for the hypervirulent K2 reference strain CG43. Hypervirulent K. pneumoniae isolates are generally defined as carrying K. pneumoniae virulence plasmid–associated loci and having a hypermucoviscous phenotype (including a positive string test result), which is dependent on regulator RmpA (40,41). We measured the hypermucoviscosity of the first isolates from all patients using both the string test and a centrifugation assay; 6 of 7 isolates formed strings, and 5 of 7 isolates were hypermucoviscous according to the centrifugation assay (Figure 2, panel A). Only ENT596 was negative by both tests.

The virulence potential of the carbapenem-resistant hypervirulent K. pneumoniae isolates was further determined in an intraperitoneal mouse infection model. The first isolates from 6 of 7 patients killed >50% of the infected mice within 96 hours; only ENT596 (like control isolate ENT495, a CRKP strain carrying pKPC2 but not hypervirulent) did not kill any mice (Figure 2, panel B). Serotype K1 isolates were the most virulent, and serotype K20 isolates took longer to kill. The virulence of ENT596 did not correlate with its predicted score; this isolate demonstrated concurrent loss of hypermucoviscosity and virulence in mice (Table 1; Figure 2), which might have been caused by the loss of expression of the virulence genes. The average length of hospitalization of the 7 patients harboring these isolates was 97 days, which was much longer than the average length of stay for 249 patients with carbapenem-resistant Enterobacteriaceae infection (38 days) (8). Taking into account all our evidence, we conclude that the isolates from 6 of 7 patients (A2, A4, A6, A8, A12, and A14) are phenotypically hypervirulent, and the isolates from patient A15 are phenotypically nonhypervirulent (although these isolates have a hypervirulent genetic background).

Highly Conserved Plasmid Harboring blaKPC-2 on All Carbapenem-Resistant Hypervirulent K. pneumoniae Isolates

We screened the assemblies of all 18 carbapenem-resistant hypervirulent K. pneumoniae isolates for acquired antimicrobial resistance genes using ResFinder (25) and CARD (26). Except for endogenous penicillin resistance, hypervirulent K. pneumoniae isolates are generally considered to be susceptible to antimicrobial drugs. Our search results showed that SGH10 harbored the β-lactam resistance gene blaSHV-11 and resistance genes against fluoroquinolones (oqxA and oqxB) and fosfomycins (fosA6) (Table 2). In total, 17 of 18 isolates carried these 3 resistance genes; 1 isolate from patient A15 (ENT686) did not have the oqxA and oqxB genes, and these genes were also not detectable by PCR. All isolates carried an identical set of the following 4 genes: blaKPC-2, blaTEM-1A, blaTEM-1B, and mph(A). In the 5 completely sequenced genomes (ENT494, ENT646, and ENT1734 [patient A2]; ENT1192 [patient A14]; and ENT607 [patient A15]; Appendix Table), we located these 4 genes on a 71,861-bp plasmid, which we named pKPC2. The sequences of the pKPC2s in the 4 isolates from patients A2 and A14 were identical. The pKPC2 in ENT607 from patient A15 had only 1-bp difference.

Figure 3

Thumbnail of Main features of pKPC2 from Klebsiella pneumoniae isolate ENT494, Singapore, 2013, and comparison with pSA20021456.2. Image was generated by using SnapGene Viewer (https://www.snapgene.com) and Easyfig (https://github.com/mjsull/Easyfig). KPC, Klebsiella pneumoniae carbapenemase; oriT, origin of transfer; T4SS, type IV secretion system.

Figure 3. Main features of pKPC2 from Klebsiella pneumoniae isolate ENT494, Singapore, 2013, and comparison with pSA20021456.2. Image was generated by using SnapGene Viewer (https://www.snapgene.com) and Easyfig (https://github.com/mjsull/Easyfig). KPC, Klebsiella pneumoniae...

A blastn search for pKPC2 revealed that the highest hit was a plasmid from Salmonella enterica (pSA20021456.2, GenBank accession no. CP030221), which covered 74% of pKPC2 with >99% identity (Figure 3). No attribute information was available for the Salmonella strain, and pSA20021456.2 carries no antimicrobial drug resistance genes. No incompatibility groups were detected on either plasmid by PlasmidFinder.

Figure 4

Thumbnail of Maximum-likelihood analysis of pKPC2 plasmids from carbapenem-resistant hypervirulent Klebsiella pneumoniae isolates, Singapore, 2013–2015. pKPC2_494 was used as reference. Labels indicate isolate no._patient no._K serotype_sequence type. Days between isolate collection are indicated. Scale bar indicates nucleotide changes per base pair. KPC, Klebsiella pneumoniae carbapenemase; ST, sequence type.

Figure 4. Maximum-likelihood analysis of pKPC2 plasmids from carbapenem-resistant hypervirulent Klebsiella pneumoniae isolates, Singapore, 2013–2015. pKPC2_494 was used as reference. Labels indicate isolate no._patient no._K serotype_sequence type. Days between isolate collection are indicated....

We performed a phylogenetic analysis of the pKPC2 sequences carried in the first isolates and other select isolates from all 7 patients, including the pKPC2 from ENT494 (i.e., pKPC2_494) as reference (Figure 4). This analysis revealed that all isolates carried sequences almost identical to pKPC2_494 (coverage and identity >99%). Because all isolates carried the 4-gene set, they probably had a plasmid closely related to pKPC2_494. Three patients had multiple isolates with pKPC2. The clinical records show long time-interval gaps of antimicrobial drug nonexposure between some isolates. The comparison also shows that the pKPC2-related plasmids were remarkably stable; they were maintained in bacteria with few changes for 90–281 days in the patients not undergoing antimicrobial drug treatment (Figure 4).

Figure 5

Thumbnail of Conjugation ability of pKPC2 from carbapenem-resistant hypervirulent Klebsiella pneumoniae isolates, Singapore, 2013–2014, to Escherichia coli SLC568. Filter matings were performed for 4 h. The conjugation frequency is the number of CFUs of transconjugants divided by the number of CFUs of recipients. Each symbol represents the value for an individual clone (n = 10) from 3 independent experiments. Horizontal bars indicate means and error bars SD. KPC, Klebsiella pneumoniae carbapenem

Figure 5. Conjugation ability of pKPC2 from carbapenem-resistant hypervirulent Klebsiella pneumoniae isolates, Singapore, 2013–2014, to Escherichia coli SLC568. Filter matings were performed for 4 h. The conjugation frequency is the number of CFUs...

Besides resistance genes, pKPC2 had a complete set of conjugative machinery with all 4 essential modules (oriT, relaxase, type IV coupling protein, and a type IV secretion system cluster), suggesting the plasmid is self-transmissible. The Salmonella plasmid pSA20021456.2 has a relaxase, type IV coupling protein, and type IV secretion system cluster similar to pKPC2 but no oriT site. We selected 3 isolates that had only 1 antimicrobial drug resistance plasmid to assess the transmissibility of pKPC2. We performed filter mating on LB agar using the kanamycin-resistant E. coli strain SLC568 as the recipient. After 4 hours of incubation, ≈80% of recipients (≈0.8 × 100 transconjugate/recipient) had received pKPC2 from ENT596 and ENT1061 (Figure 5). The conjugation frequency was ≈0.2% (≈2.0 × 10–4 transconjugate/recipient) when ENT494 was the donor. We confirmed the transconjugants acquired the blaKPC-2 gene by PCR (using 10 colonies for each donor). K serotype, sequence type, and hypermucoviscosity of donors could not explain the observed differences in conjugation efficiency.

To assess the role of pKPC2 in conferring antimicrobial drug resistance to host strains, we measured the MICs of antimicrobial drugs against the 3 isolates from patient A2 and compared with SGH10 (Table 3). SGH10 was resistant to penicillins and fosfomycin but susceptible to the 2 fluroquinolones tested, even though the strain carried the fluroquinolone efflux pump genes oqxA and oqxB (Table 2). This finding is consistent with the low oqxB expression seen for most K. pneumoniae strains (42). SGH10 was susceptible to cephems and carbapenems. In contrast, all 3 isolates from patient A2 were resistant to ceftriaxone, imipenem, and meropenem (Table 3), most likely because of the presence of pKPC2. These data show that pKPC2 is a highly transmissible plasmid that confers resistance to all 3 types of β-lactams.

Within-Patient Microevolution of Carbapenem-Resistant Hypervirulent K. pneumoniae Isolates

Figure 6

Thumbnail of Timeline showing antimicrobial drug exposure and plasmid changes in 3 carbapenem-resistant hypervirulent Klebsiella pneumoniae isolates from patient A2, Singapore, 2013–2014. pMDR646 contains genes aac(6’)-lb-cr,blaOXA-1, qnrB1, catB3, and dfrA14. pMDR1734 contains genes aac(6’)-lb-cr,blaOXA-1, and catB3. pKPC2 contains genes blaKPC-2, blaTEM-1A, blaTEM-1B, and mph(A). KPC, Klebsiella pneumoniae carbapenemase; KPVP, Klebsiella pneumoniae virulence plasmid; MDR, multidrug resistance.

Figure 6. Timeline showing antimicrobial drug exposure and plasmid changes in 3 carbapenem-resistant hypervirulent Klebsiella pneumoniae isolates from patient A2, Singapore, 2013–2014. pMDR646 contains genes aac(6’)-lb-cr,blaOXA-1, qnrB1, catB3, and dfrA14. pMDR1734 contains genes...

Using multiple isolates from the same patient, we set out to determine the changes that occurred in the genome of 1 carbapenem-resistant hypervirulent K. pneumoniae population over the course of an infection. This analysis enabled us to track the carriage of genes conferring carbapenem resistance and MDR in the bacteria versus antimicrobial drug exposure over time. With the available clinical data from patient A2, we reconstructed a timeline of the evolution of the 3 isolates from this patient, showing their plasmid content and antimicrobial drug exposure (Figure 6).

In addition to the chromosome, K. pneumoniae virulence plasmid, and pKPC2, all 3 isolates from patient A2 carried 2 or 3 additional plasmids (Appendix Table). Isolates were of the same infecting strain but lost or gained MDR plasmids over time. The K. pneumoniae virulence plasmid and pKPC2 were stable, showing few changes over a year. Treatment with gentamicin and ciprofloxacin correlated with the appearance of an MDR plasmid in ENT646 that encoded resistance genes to both classes of antimicrobial drugs. This 165-kb MDR plasmid (named pMDR646) carried aac(6')-lb-cr, blaOXA-1, qnrB1, catB3, and dfrA14. In the third isolate from patient A2 (ENT1734), the MDR plasmid downsized to 100 kb (pMDR1734) and carried only aac(6')-lb-cr, blaOXA-1, and catB3. The downsizing appeared to be the result of extensive deletion and reorganization (Appendix Figure). Antimicrobial susceptibility testing data also showed that this bacterium was resistant to fewer antimicrobial drugs; isolate ENT646 was resistant to 7 classes of antimicrobial drugs, and ENT1734 was resistant to 6 classes of drugs (Table 3). Both ENT646 and ENT1734 carried the broad-range resistance gene aac(6')-lb-cr, which confers resistance against aminoglycoside and fluoroquinolone antimicrobial drugs. This gene was likely responsible for the observed resistance to kanamycin, and qnrB1 (in ENT646) was likely responsible for resistance to ciprofloxacin (Table 3). Both isolates were also resistant to sulfamethoxazole, which we could not attribute to any resistance gene or mutation. All 3 isolates carried a 95-kb plasmid with unknown virulence or resistance attributes (Figure 6). The sizes of the chromosome and K. pneumoniae virulence plasmid gradually increased over time, mainly through the acquisition of mobile genetic elements.

Nine isolates were collected from patient A15 at various time points and from different anatomic sites (Table 2); all were identical in their core genomes (0 SNP differences). Two A15 isolates acquired antimicrobial drug resistance genes in addition to those on pKPC2; 1 of the first isolates, ENT607, had aadA1, mph(A), cmlA1, arr-2, and sul1, which were all on a 105-kb plasmid (named pMDR607). This plasmid appeared unstable and was absent in later isolates. The last isolate, ENT1077, had acquired tetracycline and trimethoprim resistance genes not seen in the other isolates.

Discussion

We report the coexistence of hypervirulence and carbapenem resistance within the same K. pneumoniae isolates in Singapore. These isolates dated back to 2013; however, their existence could have occurred even earlier because collection started in 2010. All carbapenem-resistant hypervirulent K. pneumoniae isolates in this study harbored a blaKPC-2 gene. In studies conducted in China, most patients infected with carbapenem-resistant hypervirulent K. pneumoniae also carried the blaKPC-2 gene (16,4345). We and others have described hypervirulent K. pneumoniae in community-acquired liver abscesses in Singapore, where most isolates are capsular serotypes K1 and K2 (6,46). Most (>80%) liver abscess isolates are estimated to belong to sublineage CG23-I (includes reference strain SGH10) (39). The carbapenem-resistant hypervirulent K. pneumoniae isolates from 5 of 7 patients in this study were K1 or K2 serotype and 6 of 7 isolates were highly virulent, as predicted. Our results suggest that pKPC2 can be stably maintained in a hypervirulent K. pneumoniae bacterial host. Thus, the possible dissemination of the blaKPC-2 gene to hypervirulent strains present in a carriage state within communities is a concern.

In a study in China, 1,838 isolates were analyzed, and 21 carbapenem-resistant hypervirulent K. pneumoniae isolates were found and classified as ST11, ST65, ST268, ST595, and ST692 (44). In another report, 5 ST11 CRKP isolates were documented as having acquired K. pneumoniae virulence plasmids (16). In these reports, a K. pneumoniae virulence plasmid or parts of one was probably co-opted into the prevalent CRKP strain in that region, which was an ST11 strain carrying the blaKPC-2 gene. According to our previous study, only 5% of CRKP isolates in Singapore were ST11 (8). However, in another study, 7 carbapenem-resistant hypervirulent K. pneumoniae isolates were identified, 4 of which were ST23 and serotype K1 (47). In 2 case studies, ST23 (hypervirulent) isolates were reported to have acquired carbapenem-resistance genes (14,48). All our isolates in this investigation had the hypervirulence background and acquired carbapenem-resistance and MDR genes; the MDR genes appeared to move in and out of the parental strain over time within the patient. Our observations are consistent with earlier reports in China involving ST65 isolates, which were likely hypervirulent, indicating that hypervirulent isolates can acquire antimicrobial drug resistance. Therefore, whether a superbug is more likely to arise from a carbapenem-resistant isolate acquiring a K. pneumoniae virulence plasmid or some of its genes versus a hypervirulent isolate acquiring MDR genes is unclear. Both ways of exchange appear possible, perhaps depending on the prevalence of the circulating sequence type in a particular setting and in vivo selection pressures.

We also show that, although isolates from different patients were similar in terms of the virulence and carbapenem-resistance plasmids, these isolates do not arise from transmission events. For patients with multiple isolates, the core genomes were highly conserved, suggesting a single infecting isolate gained or lost various antimicrobial drug resistance genes over time. For patient A2, our longitudinal data suggest that the use of distinct antimicrobial drugs drove the acquisition of resistance, though we have no direct proof of cause and effect. Of note, in patient A15, the rectal isolate had additional antimicrobial drug resistance, perhaps reflecting that the colon might serve as a reservoir where genetic exchange can take place. Six of the 18 isolates, including the last acquired isolates from the 3 patients with multiple isolates, were collected from feces or rectal swab specimens, suggesting that the intestines are a likely reservoir for persistent carriage. Last, we demonstrated as a proof-of-principle that pKPC2 can be transferred from the K. pneumoniae isolates to E. coli in vitro with high efficiency. Determining the particular characteristics of pKPC2 that make it so transmissible and stable, particularly during interactions with hypervirulent isolates, and how pKPC2 is acquired by the recipient is essential.

Therefore, this report serves to alert infectious disease clinicians to the possible presence of hypervirulence in MDR or carbapenem-resistant colonizing isolates; patients harboring these isolates are at risk of developing invasive infections. With timely (rather than retrospective) whole-genome sequencing of bacteria, identifying patients harboring hypervirulent and multidrug or carbapenem-resistant isolates at high risk for death should be possible. These patients can be selected for appropriate infection control measures, treatment, and close monitoring. Developing strategies to decolonize the gastrointestinal tracts of patients with such isolates would help minimize the release of these potential superbugs into the community.

Mr. Chen is a research associate at the Yong Loo Lin School of Medicine at National University of Singapore, Singapore. His main research interests are regulation of virulence and antimicrobial drug resistance in bacterial pathogens, including K. pneumoniae.

Top

Acknowledgments

We thank the CaPES study group for their support. This group included Benjamin Cherng, Deepak Rama Narayana, Douglas Chan Su Gin, De Partha Pratim, Hsu Li Yang, Indumathi Venkatachalam, Jeanette Teo, Kalisvar Marimuthu, Koh Tse Hsien, Nancy Tee, Nares Smitasin, Ng Oon Tek, Ooi Say Tat, Raymond Fong, Raymond Lin Tzer Pin, Surinder Kaur Pada, Tan Thean Yen, and Thoon Koh Cheng. We thank Ewan M. Harrison for his critical reading of the manuscript.

This work was supported by the National University of Singapore, Yong Loo Lin School of Medicine Aspiration Fund (NUHSRO/2014/068/AF New Idea/03), and National Medical Research Council (NMRC) collaborative grant Collaborative Solutions Targeting Antimicrobial Resistance Threats in Health Systems (CoSTAR-HS, HS/ARGSeedGrant/2017/03) to Y.-H.G. Additional grant support was provided by CoSTAR-HS (NMRC CGAug16C005), NMRC Clinician Scientist Award (NMRC/CSA-INV/0007/2016), and NMRC Clinician Scientist Award (MOH-000276).

Top

References

  1. Willyard  C. The drug-resistant bacteria that pose the greatest health threats. Nature. 2017;543:15. DOIPubMed
  2. David  S, Reuter  S, Harris  SR, Glasner  C, Feltwell  T, Argimon  S, et al.; EuSCAPE Working Group; ESGEM Study Group. Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread. Nat Microbiol. 2019;4:191929. DOIPubMed
  3. Munoz-Price  LS, Poirel  L, Bonomo  RA, Schwaber  MJ, Daikos  GL, Cormican  M, et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis. 2013;13:78596. DOIPubMed
  4. Government of the United Kingdom. Review on antimicrobial resistance. tackling drug-resistant infections globally: an overview of our work. 2016 Mar [cited 2019 Aug 22]. https://amr-review.org/sites/default/files/Tackling%20drug-resistant%20infections%20-%20An%20overview%20of%20our%20work_IncHealth_LR_NO%20CROPS.pdf
  5. World Health Organization. Worldwide country situation analysis: response to antimicrobial resistance. 2015 Apr 29 [cited 2019 Aug 22]. https://www.who.int/drugresistance/documents/situationanalysis
  6. Lee  IR, Molton  JS, Wyres  KL, Gorrie  C, Wong  J, Hoh  CH, et al. Differential host susceptibility and bacterial virulence factors driving Klebsiella liver abscess in an ethnically diverse population. Sci Rep. 2016;6:29316. DOIPubMed
  7. Chew  KL, Lin  RTP, Teo  JWP. Klebsiella pneumoniae in Singapore: hypervirulent infections and the carbapenemase threat. Front Cell Infect Microbiol. 2017;7:515. DOIPubMed
  8. Marimuthu  K, Venkatachalam  I, Khong  WX, Koh  TH, Cherng  BPZ, Van La  M, et al.; Carbapenemase-Producing Enterobacteriaceae in Singapore (CaPES) Study Group. Clinical and molecular epidemiology of carbapenem-resistant Enterobacteriaceae among adult inpatients in Singapore. Clin Infect Dis. 2017;64(suppl_2):S6875. DOIPubMed
  9. Siu  LK, Yeh  KM, Lin  JC, Fung  CP, Chang  FY. Klebsiella pneumoniae liver abscess: a new invasive syndrome. Lancet Infect Dis. 2012;12:8817. DOIPubMed
  10. Russo  TA, Marr  CM. Hypervirulent Klebsiella pneumoniae. Clin Microbiol Rev. 2019;32:e00001-19. DOIPubMed
  11. Lee  CR, Lee  JH, Park  KS, Kim  YB, Jeong  BC, Lee  SH. Global dissemination of carbapenemase-producing Klebsiella pneumoniae: epidemiology, genetic context, treatment options, and detection methods. Front Microbiol. 2016;7:895. DOIPubMed
  12. Paczosa  MK, Mecsas  J. Klebsiella pneumoniae: going on the offense with a strong defense. Microbiol Mol Biol Rev. 2016;80:62961. DOIPubMed
  13. Lee  CR, Lee  JH, Park  KS, Jeon  JH, Kim  YB, Cha  CJ, et al. Antimicrobial resistance of hypervirulent Klebsiella pneumoniae: epidemiology, hypervirulence-associated determinants, and resistance mechanisms. Front Cell Infect Microbiol. 2017;7:483. DOIPubMed
  14. Roulston  KJ, Bharucha  T, Turton  JF, Hopkins  KL, Mack  DJF. A case of NDM-carbapenemase-producing hypervirulent Klebsiella pneumoniae sequence type 23 from the UK. JMM Case Rep. 2018;5:e005130. DOIPubMed
  15. Andrade  LN, Vitali  L, Gaspar  GG, Bellissimo-Rodrigues  F, Martinez  R, Darini  AL. Expansion and evolution of a virulent, extensively drug-resistant (polymyxin B-resistant), QnrS1-, CTX-M-2-, and KPC-2-producing Klebsiella pneumoniae ST11 international high-risk clone. J Clin Microbiol. 2014;52:25305. DOIPubMed
  16. Gu  D, Dong  N, Zheng  Z, Lin  D, Huang  M, Wang  L, et al. A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study. Lancet Infect Dis. 2018;18:3746. DOIPubMed
  17. Wyres  KL, Wick  RR, Judd  LM, Froumine  R, Tokolyi  A, Gorrie  CL, et al. Distinct evolutionary dynamics of horizontal gene transfer in drug resistant and virulent clones of Klebsiella pneumoniae. PLoS Genet. 2019;15:e1008114. DOIPubMed
  18. Khong  WX, Marimuthu  K, Teo  J, Ding  Y, Xia  E, Lee  JJ, et al.; Carbapenemase-Producing Enterobacteriaceae in Singapore (CaPES) Study Group. Tracking inter-institutional spread of NDM and identification of a novel NDM-positive plasmid, pSg1-NDM, using next-generation sequencing approaches. J Antimicrob Chemother. 2016;71:30819. DOIPubMed
  19. Bankevich  A, Nurk  S, Antipov  D, Gurevich  AA, Dvorkin  M, Kulikov  AS, et al. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol. 2012;19:45577. DOIPubMed
  20. Wick  RR, Judd  LM, Gorrie  CL, Holt  KE. Unicycler: Resolving bacterial genome assemblies from short and long sequencing reads. PLOS Comput Biol. 2017;13:e1005595. DOIPubMed
  21. Lam  MMC, Wick  RR, Wyres  KL, Gorrie  CL, Judd  LM, Jenney  AWJ, et al. Genetic diversity, mobilisation and spread of the yersiniabactin-encoding mobile element ICEKp in Klebsiella pneumoniae populations. Microb Genom. 2018;4. DOIPubMed
  22. Lam  MMC, Wyres  KL, Judd  LM, Wick  RR, Jenney  A, Brisse  S, et al. Tracking key virulence loci encoding aerobactin and salmochelin siderophore synthesis in Klebsiella pneumoniae. Genome Med. 2018;10:77. DOIPubMed
  23. Wyres  KL, Wick  RR, Gorrie  C, Jenney  A, Follador  R, Thomson  NR, et al. Identification of Klebsiella capsule synthesis loci from whole genome data. Microb Genom. 2016;2:e000102. DOIPubMed
  24. Deatherage  DE, Barrick  JE. Identification of mutations in laboratory-evolved microbes from next-generation sequencing data using breseq. Methods Mol Biol. 2014;1151:16588. DOIPubMed
  25. Zankari  E, Hasman  H, Cosentino  S, Vestergaard  M, Rasmussen  S, Lund  O, et al. Identification of acquired antimicrobial resistance genes. J Antimicrob Chemother. 2012;67:26404. DOIPubMed
  26. Jia  B, Raphenya  AR, Alcock  B, Waglechner  N, Guo  P, Tsang  KK, et al. CARD 2017: expansion and model-centric curation of the comprehensive antibiotic resistance database. Nucleic Acids Res. 2017;45(D1):D56673. DOIPubMed
  27. Carattoli  A, Zankari  E, García-Fernández  A, Voldby Larsen  M, Lund  O, Villa  L, et al. In silico detection and typing of plasmids using PlasmidFinder and plasmid multilocus sequence typing. Antimicrob Agents Chemother. 2014;58:3895903. DOIPubMed
  28. Treangen  TJ, Ondov  BD, Koren  S, Phillippy  AM. The Harvest suite for rapid core-genome alignment and visualization of thousands of intraspecific microbial genomes. Genome Biol. 2014;15:524. DOIPubMed
  29. Langmead  B, Salzberg  SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9:3579. DOIPubMed
  30. Bertels  F, Silander  OK, Pachkov  M, Rainey  PB, van Nimwegen  E. Automated reconstruction of whole-genome phylogenies from short-sequence reads. Mol Biol Evol. 2014;31:107788. DOIPubMed
  31. Price  MN, Dehal  PS, Arkin  AP. FastTree 2—approximately maximum-likelihood trees for large alignments. PLoS One. 2010;5:e9490. DOIPubMed
  32. Li  X, Xie  Y, Liu  M, Tai  C, Sun  J, Deng  Z, et al. oriTfinder: a web-based tool for the identification of origin of transfers in DNA sequences of bacterial mobile genetic elements. Nucleic Acids Res. 2018;46(W1):W22934. DOIPubMed
  33. Fang  CT, Chuang  YP, Shun  CT, Chang  SC, Wang  JT. A novel virulence gene in Klebsiella pneumoniae strains causing primary liver abscess and septic metastatic complications. J Exp Med. 2004;199:697705. DOIPubMed
  34. Lai  YC, Peng  HL, Chang  HY. RmpA2, an activator of capsule biosynthesis in Klebsiella pneumoniae CG43, regulates K2 cps gene expression at the transcriptional level. J Bacteriol. 2003;185:788800. DOIPubMed
  35. Hardiman  CA, Weingarten  RA, Conlan  S, Khil  P, Dekker  JP, Mathers  AJ, et al. Horizontal transfer of carbapenemase-encoding plasmids and comparison with hospital epidemiology data. Antimicrob Agents Chemother. 2016;60:49109. DOIPubMed
  36. Khetrapal  V, Mehershahi  K, Rafee  S, Chen  S, Lim  CL, Chen  SL. A set of powerful negative selection systems for unmodified Enterobacteriaceae. Nucleic Acids Res. 2015;43:e83. DOIPubMed
  37. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically (M07-A10). Wayne (PA): The Institute; 2015.
  38. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing (M100-S28). Wayne (PA): The Institute; 2018.
  39. Lam  MMC, Wyres  KL, Duchêne  S, Wick  RR, Judd  LM, Gan  YH, et al. Population genomics of hypervirulent Klebsiella pneumoniae clonal-group 23 reveals early emergence and rapid global dissemination. Nat Commun. 2018;9:2703. DOIPubMed
  40. Chen  YT, Chang  HY, Lai  YC, Pan  CC, Tsai  SF, Peng  HL. Sequencing and analysis of the large virulence plasmid pLVPK of Klebsiella pneumoniae CG43. Gene. 2004;337:18998. DOIPubMed
  41. Yu  WL, Ko  WC, Cheng  KC, Lee  CC, Lai  CC, Chuang  YC. Comparison of prevalence of virulence factors for Klebsiella pneumoniae liver abscesses between isolates with capsular K1/K2 and non-K1/K2 serotypes. Diagn Microbiol Infect Dis. 2008;62:16. DOIPubMed
  42. Zheng  JX, Lin  ZW, Sun  X, Lin  WH, Chen  Z, Wu  Y, et al. Overexpression of OqxAB and MacAB efflux pumps contributes to eravacycline resistance and heteroresistance in clinical isolates of Klebsiella pneumoniae. Emerg Microbes Infect. 2018;7:139. DOIPubMed
  43. Yao  B, Xiao  X, Wang  F, Zhou  L, Zhang  X, Zhang  J. Clinical and molecular characteristics of multi-clone carbapenem-resistant hypervirulent (hypermucoviscous) Klebsiella pneumoniae isolates in a tertiary hospital in Beijing, China. Int J Infect Dis. 2015;37:10712. DOIPubMed
  44. Zhan  L, Wang  S, Guo  Y, Jin  Y, Duan  J, Hao  Z, et al. Outbreak by hypermucoviscous Klebsiella pneumoniae ST11 Isolates with carbapenem resistance in a tertiary hospital in China. Front Cell Infect Microbiol. 2017;7:182. DOIPubMed
  45. Lin  YT, Siu  LK, Lin  JC, Chen  TL, Tseng  CP, Yeh  KM, et al. Seroepidemiology of Klebsiella pneumoniae colonizing the intestinal tract of healthy Chinese and overseas Chinese adults in Asian countries. BMC Microbiol. 2012;12:13. DOIPubMed
  46. Zhang  R, Lin  D, Chan  EW, Gu  D, Chen  GX, Chen  S. Emergence of carbapenem-resistant serotype K1 hypervirulent Klebsiella pneumoniae strains in China. Antimicrob Agents Chemother. 2015;60:70911. DOIPubMed
  47. Cejas  D, Fernández Canigia  L, Rincón Cruz  G, Elena  AX, Maldonado  I, Gutkind  GO, et al. First isolate of KPC-2-producing Klebsiella pneumonaie sequence type 23 from the Americas. J Clin Microbiol. 2014;52:34835. DOIPubMed
  48. Zhang  Y, Zeng  J, Liu  W, Zhao  F, Hu  Z, Zhao  C, et al. Emergence of a hypervirulent carbapenem-resistant Klebsiella pneumoniae isolate from clinical infections in China. J Infect. 2015;71:55360. DOIPubMed

Top

Figures
Tables

Top

Cite This Article

DOI: 10.3201/eid2603.191230

Original Publication Date: February 06, 2020

Table of Contents – Volume 26, Number 3—March 2020

Comments

Please use the form below to submit correspondence to the authors or contact them at the following address:

Yunn-Hwen Gan, National University of Singapore, Yong Loo Lin School of Medicine, Department of Biochemistry, 8 Medical Dr, 117596, Singapore

Send To

character(s) remaining.

Comment submitted successfully, thank you for your feedback.

Top

Page created: February 20, 2020
Page updated: February 20, 2020
Page reviewed: February 20, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external